These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17728334)

  • 1. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.
    Hudson M; Thombs BD; Steele R; Watterson R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):279-84. PubMed ID: 18240196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Wakabayashi R; Kida K
    Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of self-reported physical health status in systemic sclerosis.
    Hudson M; Steele R; Lu Y; Thombs BD; Panopalis P; Baron M;
    J Rheumatol; 2009 Jun; 36(6):1226-9. PubMed ID: 19447939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.
    Hudson M; Steele R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):270-8. PubMed ID: 18240187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
    Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
    Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
    Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of psychological functioning upon systemic sclerosis patients' quality of life.
    Hyphantis TN; Tsifetaki N; Siafaka V; Voulgari PV; Pappa C; Bai M; Palieraki K; Venetsanopoulou A; Mavreas V; Drosos AA
    Semin Arthritis Rheum; 2007 Oct; 37(2):81-92. PubMed ID: 17512572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.
    Hudson M; Thombs BD; Steele R; Panopalis P; Newton E; Baron M;
    J Rheumatol; 2009 Apr; 36(4):768-72. PubMed ID: 19228662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pain in health related quality of life of patients with systemic sclerosis.
    Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
    Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
    Trad S; Amoura Z; Beigelman C; Haroche J; Costedoat N; Boutin le TH; Cacoub P; Frances C; Wechsler B; Grenier P; Piette JC
    Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
    Kampolis C; Plastiras S; Vlachoyiannopoulos P; Moyssakis I; Tzelepis G
    Scand J Rheumatol; 2008; 37(4):278-83. PubMed ID: 18612928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.
    Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB
    Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of health-related quality of life in patients treated with hemodialysis in Serbia: influence of comorbidity, age, and income.
    Stojanovic M; Stefanovic V
    Artif Organs; 2007 Jan; 31(1):53-60. PubMed ID: 17209961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.